Shuxia Guo Selected Research

Shuxia Guo Research Topics

Disease

6	Hypertension (High Blood Pressure) 01/2022 - 01/2015
4	Obesity 01/2022 - 01/2015
4	Dyslipidemias (Dyslipidemia) 01/2019 - 09/2015
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 05/2015
3	Type 2 Diabetes Mellitus (MODY) 10/2015 - 01/2015
2	Inflammation (Inflammations) 12/2020 - 05/2020
2	Abdominal Obesity 12/2017 - 01/2016
2	Overweight 01/2016 - 01/2015
2	Essential Hypertension 08/2010 - 05/2007
1	Fabry Disease (Fabry's Disease) 05/2022
1	Insulin Resistance 01/2022
1	Lymphoma (Lymphomas) 01/2022
1	Hypotension (Low Blood Pressure) 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2021
1	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 01/2021
1	Lupus Nephritis 12/2020
1	Necrosis 12/2020
1	Neoplasms (Cancer) 12/2020
1	Cardiomyopathies (Cardiomyopathy) 01/2020
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2020
1	Cysts 01/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 10/2018
1	Hypercholesterolemia 01/2016
1	Hypertriglyceridemia 01/2016
1	Hyperlipidemias (Hyperlipidemia) 01/2016
1	Vascular Diseases (Vascular Disease) 05/2015
1	Hyperhomocysteinemia 05/2015
1	Isolated Systolic Hypertension 05/2015
1	Blood Coagulation Disorders 05/2015
1	Acute Promyelocytic Leukemia 05/2015
1	Diabetes Mellitus 01/2015
1	Liver Diseases (Liver Disease) 01/2015

Drug/Important Bio-Agent (IBA)

5	LipidsIBA 05/2022 - 01/2015
3	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2017
3	Triglycerides (Triacylglycerol)IBA 01/2022 - 01/2015
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2010
3	HDL CholesterolIBA 12/2017 - 01/2016
3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 10/2015 - 01/2015
2	EnzymesIBA 01/2022 - 01/2021
2	CytokinesIBA 01/2021 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 12/2017 - 01/2015
2	oxidized low density lipoproteinIBA 01/2016 - 12/2015
1	globotriaosylceramide (globotriosylceramide)IBA 05/2022
1	pegaspargase (Oncaspar)FDA Link 01/2022
1	HDL LipoproteinsIBA 01/2022
1	Gemcitabine FDA Link 01/2022
1	Asparaginase (Elspar)FDA Link 01/2022
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	ORALIT (ORS)IBA 01/2022
1	Lipoproteins (Lipoprotein)IBA 01/2022
1	Cysteine (L-Cysteine)FDA Link 01/2021
1	phorbolIBA 12/2020
1	DNA (Deoxyribonucleic Acid)IBA 12/2020
1	InterleukinsIBA 12/2020
1	Complement C1q (C1q Complement)IBA 12/2020
1	QuercetinIBA 05/2020
1	HCEIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	AdiponectinIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 10/2018
1	CholesterolIBA 01/2018
1	LDL CholesterolIBA 01/2016
1	cerivastatin (Kazak)FDA Link 12/2015
1	Cholesterol Ester Transfer ProteinsIBA 12/2015
1	Exenatide (Byetta)FDA Link 10/2015
1	Hypoglycemic Agents (Hypoglycemics)IBA 10/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2015
1	HomocysteineIBA 05/2015
1	Biomarkers (Surrogate Marker)IBA 05/2015
1	Arsenic Trioxide (Trisenox)FDA Link 05/2015
1	Daunorubicin (Cerubidine)FDA LinkGeneric 05/2015
1	Annexin A2 (Annexin II)IBA 05/2015
1	Drug CombinationsIBA 05/2015
1	ArsenicIBA 01/2015
1	AntioxidantsIBA 01/2015
1	LuteinIBA 01/2015
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 08/2010
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 05/2007

Therapy/Procedure

3	Therapeutics 02/2021 - 01/2015
1	Drug Therapy (Chemotherapy) 01/2022
1	Heart Transplantation (Grafting, Heart) 01/2020